World BioNTech selects Rwanda and Senegal to produce vaccines for malaria and TB BioNTech hopes it can follow up its global COVID-19 success with the world’s first mRNA vaccines against malaria and tuberculosis. While still under development,... Nancy MAugust 28, 2021